FDA Gets $2.6 Billion to Finish Fiscal Year

President Barack Obama signed the fiscal year 2009 Omnibus Appropriations Act on Mar. 11, 2009, giving the US Food and Drug Administration $2.6 billion. The funding can be used through the fiscal year, which ends on Sept. 30, 2009.

Of the funds, $2 billion go directly to FDA. The Center for Drug Evaluation and Research will receive approximately $777 million for its activities and those of the Office of Regulatory Affairs (ORA), $41 million of which will go to the Office of Generic Drugs. The Center for Biologics Evaluation and Research will receive about $271 million for its activities and those of ORA. Approximately $511 million of the funding will come from prescription drug user fees.

In December 2007, Congress enacted the FY 2008 Omnibus Appropriations Act, which gave FDA $1.714 billion, and in June 2008, Congress gave the agency another $150 million as part of the FY 2008 emergency supplemental appropriations bill.